Most of the discussion seems to be based on the Pib-PET results, particularly in regard to the placebo results but the report also states "No improvement was observed on the secondary endpoints of brain metabolic activity,cognition and function;"
I am positive re Prana and, in fact bought more on Tuesday but this seems to be a very important outcome. One would have hoped that cognition and function would have shown "some" improvement. Perhaps Prana are still analysing the data themselves.
What do others think?
Most of the discussion seems to be based on the Pib-PET results,...
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $5.1K | 1.02M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 48 | 69461182 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 21658481 | 10 |
View Market Depth
| Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.5¢ |
Change
0.000 ( 10.0 %) |
||||
| Open | High | Low | Volume | ||
| 0.5¢ | 0.5¢ | 0.5¢ | 1258823 | ||
| Last updated 15.59pm 31/05/2024 ? | |||||
| ATH (ASX) Chart |